Interact to see
Advertisement
Advertisement
HGHRX vs JNGLX
HGHRX vs JNGLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
HGHRX vs. JNGLX commentary
Nov 14, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a StrongBuy and JNGLX is a Buy.
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.95B vs. HGHRX (837M). JNGLX pays higher dividends than HGHRX: JNGLX (0.31) vs HGHRX (0.00). HGHRX was incepted earlier than JNGLX: HGHRX (19 years) vs JNGLX (27 years). HGHRX (1.63) is less costly to investors than JNGLX (0.80). HGHRX is a more actively managed with annual turnover of: 40.00 vs. JNGLX (35.00). HGHRX has a lower initial minimum investment than JNGLX: HGHRX (0) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : 4.52 vs. HGHRX (-0.95). JNGLX return over 5 years is better than : 15.51 vs. HGHRX (-13.79).
| HGHRX | JNGLX | HGHRX / JNGLX | |
| Total Expense Ratio | 1.63 | 0.80 | 204% |
| Annual Report Gross Expense Ratio | 1.63 | 0.80 | 204% |
| Fund Existence | 19 years | 27 years | - |
| Gain YTD | 11.343 | 19.237 | 59% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 837M | 4.95B | 17% |
| Annual Yield % from dividends | 0.00 | 0.31 | - |
| Returns for 1 year | -0.95 | 4.52 | -21% |
| Returns for 3 years | 10.63 | 26.51 | 40% |
| Returns for 5 years | -13.79 | 15.51 | -89% |
| Returns for 10 years | -1.82 | 53.52 | -3% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement